American Century Companies
DCPH

American Century Companies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

American Century Companies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,247
Closed -$932K – 2988
2024
Q1 		$932K Buy
59,247
+13,440
+29% +$207K ﹤0.01% 2181
2023
Q4 		$739K Buy
45,807
+27,107
+145% +$346K ﹤0.01% 2202
2023
Q3 		$238K Buy
18,700
+3,429
+22% +$47.3K ﹤0.01% 2537
2023
Q2 		$215K Buy
15,271
+56
+0.4% +$801 ﹤0.01% 2508
2023
Q1 		$229K Buy
15,215
+3,277
+27% +$54.7K ﹤0.01% 2379
2022
Q4 		$196K Buy
+11,938
New +$194K ﹤0.01% 2346
2022
Q1 		– Sell
-304,451
Closed -$2.97M – 2371
2021
Q4 		$2.97M Buy
304,451
+9,648
+3% +$181K ﹤0.01% 1212
2021
Q3 		$10M Sell
294,803
-398
-0.1% -$12.7K 0.01% 845
2021
Q2 		$10.8M Buy
295,201
+31,842
+12% +$1.23M 0.01% 797
2021
Q1 		$11.8M Buy
263,359
+48,557
+23% +$2.26M 0.01% 747
2020
Q4 		$12.3M Buy
214,802
+12,906
+6% +$765K 0.01% 732
2020
Q3 		$10.4M Buy
201,896
+44,782
+29% +$2.19M 0.01% 705
2020
Q2 		$9.38M Buy
157,114
+86,366
+122% +$4.62M 0.01% 686
2020
Q1 		$2.91M Buy
+70,748
New +$3.93M ﹤0.01% 797

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

American Century Companies's DCPH Position: Q2 2024 in Review

American Century Companies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 59,247 shares — an estimated $932K sold.

American Century Companies first reported a position in DCPH in Q1 2020 and held it in 14 quarters. The position peaked at $12.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • American Century Companies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American Century Companies sold 59,247 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $932K.
  • American Century Companies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • American Century Companies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $12.3M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.